{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:48:34Z","timestamp":1791298114173,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.tem.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T22:57:53Z","timestamp":1453330673000},"page":"123-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Local Control of Aldosterone Production and Primary Aldosteronism"],"prefix":"10.1016","volume":"27","author":[{"given":"Enzo","family":"Lalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Barhanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Christina","family":"Zennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Warth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2016.01.003_bib0370","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mce.2014.12.004","article-title":"Somatic mutations of the ATP1A1 gene and aldosterone-producing adenomas","volume":"408","author":"Gomez-Sanchez","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2016.01.003_bib0375","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11906-014-0439-7","article-title":"Aldosterone excess and resistant hypertension: investigation and treatment","volume":"16","author":"Stowasser","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.tem.2016.01.003_bib0380","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/15734021113099990008","article-title":"Diagnosis and treatment of unilateral forms of primary aldosteronism","volume":"9","author":"Viola","year":"2013","journal-title":"Curr. Hypertens. Rev."},{"key":"10.1016\/j.tem.2016.01.003_bib0385","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.01.003_bib0390","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2016.01.003_bib0395","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/HJH.0b013e3283060f0c","article-title":"Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma","volume":"26","author":"Letavernier","year":"2008","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2016.01.003_bib0400","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.01.003_bib0405","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways","volume":"84","author":"Sp\u00e4t","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tem.2016.01.003_bib0410","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/EJE-13-0308","article-title":"Autocrine\/paracrine regulatory mechanisms in adrenocortical neoplasms responsible for primary adrenal hypercorticism","volume":"169","author":"Lefebvre","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2016.01.003_bib0415","doi-asserted-by":"crossref","first-page":"I124","DOI":"10.1161\/01.HYP.6.2_Pt_2.I124","article-title":"Effect of changes in sodium or potassium balance, and nephrectomy, on adrenal renin and aldosterone concentrations","volume":"6","author":"Doi","year":"1984","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2016.01.003_bib0420","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1210\/endo.140.2.6489","article-title":"Losartan and angiotensin II inhibit aldosterone production in anephric rats via different actions on the intraadrenal renin\u2013angiotensin system","volume":"140","author":"Peters","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2016.01.003_bib0425","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/01.HYP.33.4.1025","article-title":"Local renin\u2013angiotensin system is involved in K+-induced aldosterone secretion from human adrenocortical NCI-H295 cells","volume":"33","author":"Hilbers","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2016.01.003_bib0430","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ar.1092270114","article-title":"Renin immunohistochemistry in the adrenal gland of the mouse fetus and neonate","volume":"227","author":"Kon","year":"1990","journal-title":"Anat. Rec."},{"key":"10.1016\/j.tem.2016.01.003_bib0435","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/en.2004-1102","article-title":"Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice","volume":"146","author":"Lee","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2016.01.003_bib0440","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/en.2013-1101","article-title":"Severe hyperaldosteronism in neonatal Task3 potassium channel knockout mice is associated with activation of the intra-adrenal renin\u2013angiotensin system","volume":"154","author":"Bandulik","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2016.01.003_bib0445","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1210\/jcem.86.10.7917","article-title":"Production and metabolism of serotonin (5-HT) by the human adrenal cortex: paracrine stimulation of aldosterone secretion by 5-HT","volume":"86","author":"Lefebvre","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.01.003_bib0450","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1210\/jcem.87.3.8327","article-title":"Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies","volume":"87","author":"Lefebvre","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.01.003_bib0455","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1210\/jc.2008-1340","article-title":"Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma","volume":"94","author":"Lampron","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.01.003_bib0460","doi-asserted-by":"crossref","first-page":"E550","DOI":"10.1210\/jc.2014-3660","article-title":"Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas","volume":"100","author":"Duparc","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.01.003_bib0465","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-0029-1243602","article-title":"Aberrant hormone receptors in primary aldosteronism","volume":"42","author":"Mazzuco","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.tem.2016.01.003_bib0470","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/me.2003-0005","article-title":"The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production","volume":"18","author":"Bassett","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tem.2016.01.003_bib0475","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1677\/JME-09-0143","article-title":"Adrenocortical development and cancer: focus on SF-1","volume":"44","author":"Lalli","year":"2010","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.tem.2016.01.003_bib0480","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1210\/en.2008-0667","article-title":"Differential effects of high and low Steroidogenic Factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells","volume":"150","author":"Ye","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2016.01.003_bib0485","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mce.2010.11.014","article-title":"The Wnt\/beta-catenin pathway in adrenocortical development and cancer","volume":"332","author":"El Wakil","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2016.01.003_bib0490","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1242\/dev.021493","article-title":"Targeted disruption of \u03b2-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex","volume":"135","author":"Kim","year":"2008","journal-title":"Development"},{"key":"10.1016\/j.tem.2016.01.003_bib0495","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/en.2011-1205","article-title":"Aldosterone producing adenoma formation in the adrenal cortex involves expression of stem\/progenitor cell markers","volume":"152","author":"Boulkroun","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2016.01.003_bib0500","doi-asserted-by":"crossref","DOI":"10.1111\/cen.12873","article-title":"Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype","author":"Scholl","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2016.01.003_bib0505","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1504869","article-title":"Pregnancy, primary aldosteronism, adrenal CTNNB1 mutations","volume":"373","author":"Teo","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2016.01.003_bib0510","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/hmg\/ddq029","article-title":"Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development","volume":"19","author":"Berthon","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tem.2016.01.003_bib0515","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/hmg\/ddt484","article-title":"WNT\/\u03b2-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production","volume":"23","author":"Berthon","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tem.2016.01.003_bib0520","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.1210\/jc.2010-1885","article-title":"Wnt\/\u03b2-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors","volume":"96","author":"Bonnet","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.01.003_bib0525","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1158\/1078-0432.CCR-10-2006","article-title":"\u03b2-Catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma","volume":"17","author":"Gaujoux","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2016.01.003_bib0530","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-14-1113","article-title":"PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases","volume":"172","author":"Thiel","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2016.01.003_bib0535","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mce.2011.10.002","article-title":"Sonic hedgehog signaling during adrenal development","volume":"351","author":"Laufer","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2016.01.003_bib0540","first-page":"863","article-title":"TASK (TWIK-related acid-sensitive K+ channel) is expressed in glomerulosa cells of rat adrenal cortex and inhibited by angiotensin II","volume":"14","author":"Czirjak","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tem.2016.01.003_bib0545","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.emboj.7601934","article-title":"Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis","volume":"27","author":"Heitzmann","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.tem.2016.01.003_bib0550","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1073\/pnas.0712000105","article-title":"TASK channel deletion in mice causes primary aldosteronism","volume":"105","author":"Davies","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2016.01.003_bib0555","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/HYPERTENSIONAHA.111.189662","article-title":"TASK-3 channel deletion in mice recapitulates low-renin essential hypertension","volume":"59","author":"Guagliardo","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2016.01.003_bib0560","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1210\/en.2012-1527","article-title":"Task3 potassium channel gene invalidation causes low renin and salt-sensitive arterial hypertension","volume":"153","author":"Penton","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2016.01.003_bib0565","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1093\/hmg\/dds333","article-title":"Dkk3 is a component of the genetic circuitry regulating aldosterone biosynthesis in the adrenal cortex","volume":"21","author":"El Wakil","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tem.2016.01.003_bib0570","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajhg.2014.06.002","article-title":"Effects of long-term averaging of quantitative blood pressure traits on the detection of genetic associations","volume":"95","author":"Ganesh","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tem.2016.01.003_bib0575","doi-asserted-by":"crossref","first-page":"E2160","DOI":"10.1210\/jc.2012-2196","article-title":"Variations in the potassium channel genes KCNK3 and KCNK9 in relation to blood pressure and aldosterone production: an exploratory study","volume":"97","author":"Jung","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.01.003_bib0580","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/ng.3405","article-title":"Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation","volume":"47","author":"Kato","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2016.01.003_bib0585","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tem.2016.01.003_bib0590","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2016.01.003_bib0595","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.01.003_bib0600","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma","volume":"65","author":"Zheng","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2016.01.003_bib0605","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2016.01.003_bib0610","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2016.01.003_bib0615","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2016.01.003_bib0620","doi-asserted-by":"crossref","first-page":"e06315","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.tem.2016.01.003_bib0625","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1210\/en.2011-1733","article-title":"Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis","volume":"153","author":"Oki","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2016.01.003_bib0630","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2016.01.003_bib0635","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.110.158543","article-title":"Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism","volume":"56","author":"Boulkroun","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2016.01.003_bib0640","doi-asserted-by":"crossref","first-page":"E1341","DOI":"10.1210\/jc.2013-4255","article-title":"Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?","volume":"99","author":"Dekkers","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.01.003_bib0645","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/HYPERTENSIONAHA.115.05993","article-title":"Different somatic mutations in multinodular adrenals with aldosterone-producing adenoma","volume":"66","author":"Fernandes-Rosa","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2016.01.003_bib0650","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2016.01.003_bib0655","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ng.2956","article-title":"Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors","volume":"46","author":"Goh","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2016.01.003_bib0660","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1126\/science.1249480","article-title":"Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome","volume":"344","author":"Cao","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.tem.2016.01.003_bib0665","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1126\/science.1252328","article-title":"Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome","volume":"344","author":"Sato","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.tem.2016.01.003_bib0670","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome","volume":"369","author":"Assi\u00e9","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2016.01.003_bib0675","doi-asserted-by":"crossref","first-page":"E900","DOI":"10.1210\/jc.2014-4167","article-title":"Primary adosteronism and ARMC5 variants","volume":"100","author":"Zilbermint","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.01.003_bib0680","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.01.003_bib0685","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","article-title":"Development of monoclonal antibodies against human CYP11B1 and CYP11B2","volume":"383","author":"Gomez-Sanchez","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2016.01.003_bib0690","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2014.05.002","article-title":"Adrenal CYP11B1\/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies","volume":"392","author":"Nakamura","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2016.01.003_bib0695","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2016.01.003_bib0700","unstructured":"Omata, K. et al. (2015) Aldosterone-stimulating somatic mutations are common in normal Japanese adrenal glands. Presented at the 5th International Adrenal Cancer Symposium, Ann Arbor (MI), 14\u201315 October, 2015, Global Science\/Humanistic Solutions"},{"key":"10.1016\/j.tem.2016.01.003_bib0705","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1038\/oncsis.2015.20","article-title":"Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of \u03b2-catenin in adrenocortical carcinoma","volume":"4","author":"Lef\u00e8vre","year":"2015","journal-title":"Oncogenesis"},{"key":"10.1016\/j.tem.2016.01.003_bib0710","doi-asserted-by":"crossref","first-page":"E836","DOI":"10.1210\/jc.2015-1734","article-title":"LGR5 activates non-canonical Wnt-signaling and inhibits aldosterone production in the human adrenal","volume":"100","author":"Shaikh","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.01.003_bib0715","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/HYPERTENSIONAHA.111.00662","article-title":"Abnormal aldosterone physiology and cardiometabolic risk factors","volume":"61","author":"Vaidya","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2016.01.003_bib0720","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/HYPERTENSIONAHA.114.03231","article-title":"Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk","volume":"63","author":"Brown","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2016.01.003_bib0725","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00424-014-1628-6","article-title":"Two-pore domain potassium channels in the adrenal cortex","volume":"467","author":"Bandulik","year":"2015","journal-title":"Pfl\u00fcgers Arch."},{"key":"10.1016\/j.tem.2016.01.003_bib0730","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1210\/en.2013-1944","article-title":"Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas","volume":"155","author":"Tauber","year":"2014","journal-title":"Endocrinology"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276016000163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276016000163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T03:20:23Z","timestamp":1537068023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276016000163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1043276016000163"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2016.01.003","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local Control of Aldosterone Production and Primary Aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}